Merck KGaA to ask EU agency to reconsider MS oral drug

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Merck KGaA to ask EU agency to reconsider MS oral drug

Postby MSUK » Mon Oct 11, 2010 1:44 am


German drugmaker Merck KGaA plans to ask a European watchdog to review a negative opinion issued on multiple sclerosis drug cladribine last month that said the drug's risks outweighed its benefits.

"Merck is committed to the potential of cladribine tablets to meet an unmet medical need as an oral, short-course, disease-modifying drug for multiple sclerosis," the group said in a statement on Monday.

The drug was dealt a major blow in September when the Committee for Medicinal Products for Human Use (CHMP), whose view is invariably adopted by the European Commission for approval of decisions, found that the drug may not be fit for approval. [ID:nLDE68N04J]... Read More - ... ageid/1629
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service